Clinical Trials Directory

Trials / Conditions / Breast Diseases

Breast Diseases

89 registered clinical trials studyying Breast Diseases10 currently recruiting.

StatusTrialSponsorPhase
RecruitingConstruction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal A
NCT07500428
Peking Union Medical College Hospital
Recruiting18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
NCT06335069
Maastricht University Medical CenterPhase 2
Active Not RecruitingA Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
NCT07038369
Atavistik Bio, IncPhase 1
RecruitingA Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patie
NCT07010939
FangYi
RecruitingA Study of Breast Cancer Risk Factors and Outcomes of People in Florida
NCT06780176
Memorial Sloan Kettering Cancer Center
RecruitingBreast 3DUS ABUS System Comparison
NCT06118996
Western University, CanadaN/A
Not Yet RecruitingA Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer
NCT06341283
The Affiliated Hospital of Qingdao University
RecruitingSacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINST
NCT05465031
Silesian Centre for Heart DiseasesPhase 4
UnknownReal World Evaluation of Lunit INSIGHT MMG Technology
NCT06232070
Lunit Inc.
CompletedSerratus Posterior Superior Interfascial Plane Block for Breast Surgery
NCT05972083
Medipol UniversityN/A
CompletedThe Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland
NCT06187350
Ostergotland County Council, Sweden
RecruitingPredicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advan
NCT06805812
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Active Not RecruitingExplore Association Models Between Environmental Hormones andBreast Cancer
NCT06765395
Pei-Hung Liao
Active Not RecruitingStudying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
NCT04711109
Alliance for Clinical Trials in OncologyPhase 3
UnknownEvaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes
NCT05792475
TaiHao Medical Inc.N/A
CompletedVacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Pe
NCT05665894
University of Rome Tor Vergata
RecruitingStudy of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
NCT05386108
Stemline Therapeutics, Inc.Phase 1 / Phase 2
UnknownBispectral Index and Patient State Index During General Anesthesia With Remimazolam
NCT05432050
Seoul National University Hospital
Active Not RecruitingLymphaticovenous Anastomosis as Treatment for Lymphedema
NCT05441943
Odense University HospitalN/A
CompletedEffectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast Lesions
NCT05327218
Fondation Hôpital Saint-Joseph
CompletedDifferent Volumes of Erector Spinae Plane Block for Breast Surgery
NCT05232084
Medipol UniversityN/A
Active Not RecruitingAbbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Den
NCT04854304
Abramson Cancer Center at Penn Medicine
Active Not RecruitingREGENERA Implant in Localized Non-malignant Breast Lesions Treated by Excision or Lumpectomy - Long-term Follo
NCT05533099
Tensive SRL
Active Not RecruitingContrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196
Perspectum
CompletedAGC Mode vs Minimal Flow in Breast Surgery
NCT05404269
Zonguldak Bulent Ecevit University
CompletedDotarem vs Gadobutrol Contrast for Breast MRI
NCT03730051
University of Massachusetts, WorcesterPhase 4
CompletedAdvanced Diffusion Tensor MRI for Breast Cancer
NCT04774471
Endeavor Health
CompletedThoracic Combined Spinal Epidural Anesthesia for Breast Surgery
NCT04706247
Antalya Training and Research Hospital
CompletedAesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery
NCT04554316
Albert Einstein Healthcare NetworkN/A
UnknownDiagnosis Predictive Modle for Dense Density Breast Tissue Based on Radiomics
NCT04535466
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CompletedEvaluation of TaiHao Breast Ultrasound Diagnosis Software
NCT04551105
TaiHao Medical Inc.N/A
CompletedDiagnostic Performance of Shear Wave Dispersive Imaging in Breast Lesions: Comparison With Shear Wave Elastogr
NCT06191926
Korea University Ansan Hospital
CompletedTo Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase
NCT04606329
Hanlim Pharm. Co., Ltd.Phase 3
CompletedAbbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
NCT04341129
University of ChicagoEARLY_Phase 1
UnknownPyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastati
NCT04605575
Sun Yat-sen UniversityPhase 2
CompletedPectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy Surgery
NCT04297007
Medipol UniversityN/A
CompletedUltrasound Guided Erector Spinae Plane Block
NCT06657092
Gözde Gamze UzunN/A
CompletedBreast Ultrasonography and Polycystic Ovary Syndrome
NCT04231786
Kanuni Sultan Suleyman Training and Research Hospital
UnknownPerformance Indicators and Patient Experience in 7G and 10G Vacuum-assisted Excision of Probably Benign Breast
NCT04911101
Karolinska University HospitalN/A
UnknownPyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
NCT04088110
Fuzhou General HospitalPhase 2
SuspendedSurgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy
NCT04151368
University Health Network, TorontoN/A
UnknownNeoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
NCT03756064
Zhejiang Cancer HospitalN/A
CompletedPost Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra
NCT03868514
pfm medical gmbh
UnknownPyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
NCT03910712
Peking Union Medical College HospitalPhase 2
CompletedLeflunomide in Previously Treated Metastatic Triple Negative Cancers
NCT03709446
Joseph SparanoPhase 1 / Phase 2
Enrolling By InvitationA Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychi
NCT05395949
Wuhan UniversityN/A
UnknownThe Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer
NCT03756090
Zhejiang Cancer HospitalN/A
WithdrawnPerformance Assessment of a First Generation Breast Microwave Imaging System: Study of Breast Abnormalities De
NCT02566499
University of ManitobaN/A
CompletedTo Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions
NCT03743259
Hanlim Pharm. Co., Ltd.Phase 2
UnknownMonitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulatin
NCT05814224
Centro di Riferimento Oncologico - AvianoN/A
UnknownA Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or
NCT03500380
RemeGen Co., Ltd.Phase 2 / Phase 3
CompletedComparison of Real-time and Shear Wave Elastography
NCT03487471
University Hospital, Basel, SwitzerlandN/A
UnknownPET-MRI for Axillary Staging in Node Negative Breast Cancer Patients
NCT03374826
Maastricht University Medical CenterN/A
CompletedFocal Breast Pain: Does a Normal Ultrasound Provide Reassurance?
NCT02810236
Duke UniversityN/A
CompletedRadiomics Model Based on DCE-MRI and Ultrasound Images for Breast Lesion Classification
NCT06497023
Ma Zhe
Active Not RecruitingAnastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
NCT03304080
Icahn School of Medicine at Mount SinaiPhase 1 / Phase 2
CompletedEmpowering Latinas to Obtain Breast Cancer Screenings
NCT02964234
University of Illinois at ChicagoN/A
CompletedLong Term Use of SAVI SCOUT: Pilot Study
NCT03015649
Envision Healthcare Scientific Intelligence, Inc.N/A
CompletedSingle-shot Pectoral Plane(PECs) Block Versus Continuous Local Anaesthetic Infusion Analgesia or Both PECS Blo
NCT03024697
Mater Misericordiae University HospitalPhase 4
TerminatedEffect of Body Position and Probe Position on the Localization of Breast Mass
NCT02997540
MetriTrack, Inc.
CompletedContinuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
NCT02909452
Syndax PharmaceuticalsPhase 1
CompletedCardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
NCT02897778
Syndax PharmaceuticalsPhase 1
CompletedNew Mammographic Techniques Versus MRI in Assessment of Breast Lesions
NCT06089148
Cairo University
CompletedOncoplastic Approach to Excisional Breast Biopsies
NCT02452333
Akdeniz UniversityN/A
CompletedUsing Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
NCT06069921
Ma Zhe
UnknownEvaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)
NCT02557906
King's College LondonN/A
CompletedMAC vs TIVA Ambulatory Breast Augmentation
NCT03764267
Ain Shams UniversityPhase 3
CompletedFeasibility Study of Supine Breast MRI : Comparison With Prone MRI and Comfort Assessment
NCT03088436
Institut de Cancérologie de Lorraine
UnknownCapecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
NCT01917279
Binghe XuPhase 3
CompletedRandomized, Placebo-Controlled Study: Effects of Lavender Aromatherapy on Preoperative Anxiety in Breast Patie
NCT01837966
NYU Langone HealthN/A
UnknownClinical Application of Breast Blood-oxygen Functional Imaging Technology
NCT01678170
Tianjin Medical University Cancer Institute and Hospital
CompletedBotulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
NCT01591746
Mayo ClinicPhase 3
CompletedLesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound
NCT02310776
Northwestern UniversityN/A
UnknownThe Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction
NCT01427400
University of British ColumbiaPhase 4
UnknownTRAM Procedure in Ambulatory Surgical Facility: Quality of Recovery Outcomes
NCT01438268
Women's College Hospital
UnknownA Randomized Controlled Comparative Study of Ultrasound-guided Paravertebral Blocks as Part of a Multimodal Re
NCT01654432
Women's College HospitalN/A
TerminatedMulti-Compression Spot Mammography
NCT01372215
State University of New York - Upstate Medical University
CompletedProspective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer
NCT01299987
Universitätsmedizin MannheimN/A
TerminatedClinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy
NCT01140776
Sysmex America, Inc.
UnknownClinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast Cancer
NCT01140763
Sysmex America, Inc.
CompletedClinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section Histopathology
NCT01368744
Sysmex America, Inc.
CompletedThe Study of Breast MRI Screening and Proton Magnetic Resonance Spectroscopy
NCT01749748
National Taiwan University HospitalN/A
CompletedGuarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related Fatigue
NCT01043913
Faculdade de Medicina do ABCPhase 2
CompletedClinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast Cancer
NCT01136369
Sysmex America, Inc.
CompletedT3AI-Pain After Breast Surgery
NCT00299039
Nova Scotia Health AuthorityPhase 3
CompletedEffect of Peppermint Water on Breast Crack
NCT00456404
Tabriz UniversityN/A
CompletedStudying Normal Breast Tissue and Cancer Risk
NCT00341692
National Cancer Institute (NCI)
CompletedA Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer
NCT00050427
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 2
CompletedEvaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekl
NCT00039780
BioNumerik Pharmaceuticals, Inc.Phase 3